FDAMA oversight
This article was originally published in The Tan Sheet
Executive Summary
FDA Commissioner Jane Henney, MD, to testify Oct. 21 before the Senate Health, Environment, Labor & Pensions Committee on implementation of the FDA Modernization Act. The hearing is a precursor to further oversight in the next session. Other witnesses include patient advocacy groups and other FDA stakeholders. House Commerce/Health Subcommittee will meet Oct. 19 to discuss FDAMA
|
FDA Commissioner Jane Henney, MD, to testify Oct. 21 before the Senate Health, Environment, Labor & Pensions Committee on implementation of the FDA Modernization Act. The hearing is a precursor to further oversight in the next session. Other witnesses include patient advocacy groups and other FDA stakeholders. House Commerce/Health Subcommittee will meet Oct. 19 to discuss FDAMA. |